Skip to Main Content

Paper Details

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.
Breast Cancer Res Treat
14
2017
Author NameAffiliation
John M S BartlettOntario Institute for Cancer Research
Tammy PiperEdinburgh Cancer Centre, Western General Hospital
Carrie A CunninghamEdinburgh Cancer Centre, Western General Hospital
  • 1 - 3

Datasets

Release 1.2